当前位置：首页 > 文献互助 > 互助详情

Toxicity of TAP-144-SR and TAP-144 after repeated administrations and carcinogenicity of TAP-144 in animals复制

用户S0z7gP8kaPXo 2天前 41 10 求助中 帖子自动结束时间: 2025-07-14 16:19:42

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

F Chatani
Jpn Pharmacol Ther, 1990
cir.nii.ac.jp
Toxicity of TAP-144-SR and TAP-144 after repeated administrations and carcinogenicity of TAP-144 in animals | CiNii Research … Toxicity of TAP-144-SR and TAP-144 after repeated …

上一篇：Dexmedetomidine as an Analgesic Agent with Neuroprotective Properties: Experimental and Clinical Aspects

下一篇：Overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy

互助时间线

2025-07-09 16:19:42 [发起求助]

最新发布的求助

Discovery and Characterization of Novel FGFR1 V561M Inhibitors via Virtual Screening and Molecular Dynamics Simulations 2分钟前
Discovery of a Novel EGFR PROTAC Degrader against C797S Resistance Mutation with Potent Antitumor Efficacy in NSCLC Treatment 30分钟前
Echolocation over long distances 2小时前
Nitroxide radical contrast agents for safe magnetic resonance imaging: progress, challenges, and perspectives 3小时前
Smart cities for emergency management 3小时前
Oral ENPP1 inhibitor designed using generative Al as next generation STiNG modulator for solid tumors 14小时前
癌患者の痛みに対する塩酸モルヒネ坐剤AN-631の有用性の検討 －硫酸モルヒネ徐放錠との比較― 17小时前
癌患者の疼痛治療におけるAN-631H(塩酸モルヒネ坐剤30mg)の臨床評価 17小时前
Regulatory T cells in the tumour microenvironment 17小时前
POS0734 DAPIROLIZUMAB PEGOL 显示系统性红斑狼疮疾病活动有显着改善：疗效 ... 18小时前
Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial 18小时前
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer 18小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com